Management and Execution of Pharmaceutical Stability Studies

What this document is for

The establishment of a comprehensive stability program is a strategic imperative for ensuring patient safety and maintaining uncompromising regulatory compliance.

The full text is not reproduced here. Preview any document free on the catalog page, then buy the complete catalog in your language.

Ships as

Grounded in

FDA 21 CFR 210/211 and Part 11, EU GMP (EudraLex Volume 4, including Annex 1 and Annex 11), ICH Q7–Q12, and WHO GMP. Supplied in 13 languages.

Other Quality Control documents

• Laboratory Chemical Hygiene and Safety
• Laboratory Chemical Waste Management
• Management of Laboratory Sharps Waste
• Laboratory Safety and Hazard Containment Protocols
• Analytical Method Validation and Qualification
• Bacterial Endotoxin Testing (BET)
• Bioburden Enumeration and Testing
• Bioburden Method Suitability and Microbial Recovery